期刊文献+

LyGDI在非小细胞肺癌细胞A549中的辐射抗性机制研究 被引量:1

Mechanism of the radioresistant effect of LyGDI on NSCLC A549 cells
原文传递
导出
摘要 目的 探讨LyGDI的表达在非小细胞肺癌细胞A549中的辐射抗性机制.方法 A549和作为对照的H460细胞分别受到0、2、4和6 GyX射线照射后,克隆形成试验分析辐射抗性差异,Western blot分析LyGDI和辐射敏感性关键基因环氧合酶COX-2的表达.实时荧光定量PCR分析miR-34a以及miR-34b/c在A549和H460细胞中的表达.A549细胞中转染50 nmol/L的miR-34c成熟序列,观察其对A549细胞辐射抗性以及LyGDI和COX-2基因表达的影响.结果 LyGDI和COX-2在辐射抗性的A549细胞中的表达水平高于H460细胞,miR-34a以及miR-34b/c在两种非小细胞肺癌中低表达.转染miR-34c可抑制LyGDI、COX-2和Bcl-2以及激活p21的表达,增强A549细胞细胞的辐射敏感性(t=3.85、5.89、5.12,P<0.05).结论 LyGDI诱导的COX-2的上调表达以及电离辐射效应miR-34家族的下调表达,是A549细胞辐射抗性的一个主要原因. Objective To elucidate the mechanism of radiation resistant effect of LyGDI on NSCLC A549 cells.Methods A549 and H460 cells were irradiated with X-rays of 0,2,4 and 6 Gy.The clone-forming assay was used to detect cell survival and radiosensitivity.The expressions of LyGDI and COX-2 (Cyclooxygenase-2),a key radiosensitivity-related protein,were detected using Western blot.The miR-34 families were analyzed with RT-PCR.50 nmol/L mature miR-34c was transfected into A549 cells.Results The expression levels of LyGDI and COX-2 were much higher in radioresistive A549 cells than that in H460 cells.While the expression of miR-34a was quite low and miR-34b/c was hardly found in both NSCLC cells.Transfection of miR-34c into A549 cells strongly enhanced X-ray induced apoptosis by inhibiting the activations of LyGDI,COX-2,Bcl-2 and p21.Conclusions Up-regulation of LyGDI could induce COX-2 expression.The low expression of miR-34 family might be responsible for the radiation resistance of NSCLC cells.
出处 《中华放射医学与防护杂志》 CAS CSCD 北大核心 2014年第6期411-414,共4页 Chinese Journal of Radiological Medicine and Protection
基金 国家自然科学基金(30570548,81071878)
关键词 LYGDI 非小细胞肺癌 A549细胞 辐射抗性 LyGDI Non-small-cell lung cancer A549 cell Radiation resistance
  • 相关文献

参考文献1

二级参考文献13

  • 1Aspenstrom P, Fransson A, Saras J. RhoGTPases have diverse effects on organization of the actin filament system[J]. Biochem,2004,377(2):327 -337.
  • 2Zbang B. RhoGDP dissociation inhibitors as potential targets for anticancer treatment[J]. Drug Resist Updat,2006,9(3): 134-141.
  • 3Ota T, Maeda M, Sakita-Suto S, et al. RhoGDIbeta lacking the N-terminal regulatory domain suppresses metastasis by promoting anoikis in v-src-transformed cells[J]. Clin Exp Metastasis, 2006,23(7-8) :323-334.
  • 4Yao R, Lemon WJ,Wang Y, et al. Altered gene expression profile in mouse bladder cancers induce by hydroxybutyl (butyl) nitrosamine[J]. Neoplasia, 2004,6(5): 569-577.
  • 5Olofsson B. Rho guanine dissociation inhibitors: pivotal molecules in cellular signaling[J]. Cell Signal, 1999, 11 ( 8 ) : 545- 554.
  • 6Zalcman G, Closson V, Camonis J, et al. RhoGD1-3 is a new GDP dissociation inhibitor (GDI). Identification of a non-cytosolic GDI protein interacting with the small GTP-binding proteins Rho B and Rho G[J]. Biol Chem, 1996,271:30366-30374.
  • 7Dovas A, Couchman JR. RhoGDI: multiple functions in the regulation of Rho family GTPase activities[J]. Biochem,2005, 390(1 ) : 1-9.
  • 8Etienne-Manneville S, Hall A. Rho GTPases in cell biology [J]. Nature, 2002, 420(6916): 629-635.
  • 9DerMardirossian C, Bokoch, GM. GDIs: central regulatory molecules in Rho GTPase activation[J]. Trends in Cell Biol, 2005,15(7) : 356-363.
  • 10Ueda T, Kikuchi A, Ohga N, et al. Purification and characterization from bovine brain cytosol of a novel regulatory pro tein inhibiting the dissociation of GDP from and the subsequent binding of GTP to rhoB p20, a ras p21-like GTP-binding protein[J]. Biol Chem, 1990, 265(16) : 9373-9380.

共引文献1

同被引文献7

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部